CNS Drug Reviews focuses on extensive reviews on the pharmacology, pharmacokinetics, toxicology and clinical trials of new drugs affecting the central nervous system. These peer reviewed articles are written by industrial or academic scientists who participated in the development of a particular drug. The Editorial Board is composed of eminent and highly reputable scientists.
Free full-text access is available for all 1998 and 1999 issues.
Full-text access beginning with 2000 issues is restricted to online subscribers.
|
